President Omni Eye Specialists Wilmington, North Carolina, United States
Disclosure(s): No relevant disclosure to display
Disclosure(s):
Eric Schmidt, OD: No relevant disclosure to display
This course will present pertinent clinical data on new therapeutic agents available to optometrists. Clinical indications and expectations of the new drugs will be shared and the results of clinical studies highlighted. Expected side effects will be discussed and a lengthy presentation on how to incorporate these new agents into your clinical practice will ensue.
Learning Objectives:
Upon conclusion of this activity, attendees will be able to:
Be aware of all new therapeutic agents available for optometrists to prescribe
Gain a clearer understanding of the potential side effects of each of the new agents
Understand the clinical indications for each new agent
Gain a better understanding of what the clinical expectations are for each of these new agents
Have a keener understanding of where these new agents will fit into an optometrists treatment paradigm
Become aware of how these new drugs will replace those previously used by optometrists.